Peter Timmins - Search Results

Year	Number of Results
2002	2
2003	1
2004	3
2005	6
2006	3
2007	3
2008	5
2009	4
2010	3
2011	6
2012	8
2013	6
2014	4
2015	4
2016	3
2017	5
2018	7
2019	5
2020	8
2021	4
2022	3
2023	3
2024	0

1

Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong JK, Furlong TJ, Greenfield JR, Greenup LC, Kirkpatrick CM, Ray JE, Timmins P, Williams KM. Graham GG, et al. Among authors: timmins p. Clin Pharmacokinet. 2011 Feb;50(2):81-98. doi: 10.2165/11534750-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21241070 Review.

2

Significant impact of time-of-day variation on metformin pharmacokinetics.

Türk D, Scherer N, Selzer D, Dings C, Hanke N, Dallmann R, Schwab M, Timmins P, Nock V, Lehr T. Türk D, et al. Among authors: timmins p. Diabetologia. 2023 Jun;66(6):1024-1034. doi: 10.1007/s00125-023-05898-4. Epub 2023 Mar 17. Diabetologia. 2023. PMID: 36930251 Free PMC article.

3

Cost analysis of type 2 diabetes mellitus treatment in economically developed countries.

Ramzan S, Timmins P, Hasan SS, Babar ZU. Ramzan S, et al. Among authors: timmins p. Expert Rev Pharmacoecon Outcomes Res. 2019 Feb;19(1):5-14. doi: 10.1080/14737167.2018.1513790. Epub 2018 Sep 4. Expert Rev Pharmacoecon Outcomes Res. 2019. PMID: 30146917 Review.

4

Industry News update covering July 2021.

Timmins P. Timmins P. Ther Deliv. 2021 Nov;12(11):757-774. doi: 10.4155/tde-2021-0061. Epub 2021 Oct 11. Ther Deliv. 2021. PMID: 34632811 Free article. No abstract available.

5

MUCO-DIS: a New AFM-Based Nanoscale Dissolution Technique.

Ghori MU, Nirwan JS, Asim T, Chahid Y, Farhaj S, Khizer Z, Timmins P, Conway BR. Ghori MU, et al. Among authors: timmins p. AAPS PharmSciTech. 2020 May 17;21(5):142. doi: 10.1208/s12249-020-01697-x. AAPS PharmSciTech. 2020. PMID: 32419061 Free PMC article.

6

Pharmaceutical applications of confocal laser scanning microscopy: the physical characterisation of pharmaceutical systems.

Pygall SR, Whetstone J, Timmins P, Melia CD. Pygall SR, et al. Among authors: timmins p. Adv Drug Deliv Rev. 2007 Dec 10;59(14):1434-52. doi: 10.1016/j.addr.2007.06.018. Epub 2007 Aug 25. Adv Drug Deliv Rev. 2007. PMID: 17945376 Review.

7

Formulation design, challenges, and development considerations for fixed dose combination (FDC) of oral solid dosage forms.

Desai D, Wang J, Wen H, Li X, Timmins P. Desai D, et al. Among authors: timmins p. Pharm Dev Technol. 2013 Nov-Dec;18(6):1265-76. doi: 10.3109/10837450.2012.660699. Epub 2012 Feb 16. Pharm Dev Technol. 2013. PMID: 22339230 Review.

8

Industry update: the latest developments in the field of therapeutic delivery, November 2021.

Timmins P. Timmins P. Ther Deliv. 2022 Mar;13(3):141-156. doi: 10.4155/tde-2022-0006. Epub 2022 Feb 7. Ther Deliv. 2022. PMID: 35128933 No abstract available.

9

Industry update: the latest developments in the field of therapeutic delivery, July 2023.

Timmins P. Timmins P. Ther Deliv. 2023 Sep;14(9):527-541. doi: 10.4155/tde-2023-0085. Epub 2023 Oct 3. Ther Deliv. 2023. PMID: 37786969 Free article. No abstract available.

10

Predicting feasibility and characterizing performance of extended-release formulations using physiologically based pharmacokinetic modeling.

Brown J, Crison J, Timmins P. Brown J, et al. Among authors: timmins p. Ther Deliv. 2012 Sep;3(9):1047-59. doi: 10.4155/tde.12.81. Ther Deliv. 2012. PMID: 23035591 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

83 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year